Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.
The urokinase plasminogen activator receptor (uPAR) is associated with poor prognosis in oral squamous cell carcinoma (OSCC), and increased expression of uPAR is often found at the invasive tumour front. The aim of the current study was to elucidate the role of uPAR in invasion and metastasis of OSC...
Main Authors: | Synnøve Magnussen, Elin Hadler-Olsen, Nadezhda Latysheva, Emma Pirila, Sonja E Steigen, Robert Hanes, Tuula Salo, Jan-Olof Winberg, Lars Uhlin-Hansen, Gunbjørg Svineng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4144900?pdf=render |
Similar Items
-
Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC).
by: Synnøve Magnussen, et al.
Published: (2014-01-01) -
Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor – β1 (TGF-β1) and potential effects on migration and invasion
by: Synnove Norvoll Magnussen, et al.
Published: (2017-05-01) -
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
by: Bing-Tao Zhai, et al.
Published: (2022-03-01) -
Nephronectin as a Matrix Effector in Cancer
by: Synnøve Norvoll Magnussen, et al.
Published: (2021-02-01) -
P25 Leukocyte cell surface expression of urokinase plasminogen activator receptor (uPAR) in patients with systemic lupus erythematosus
by: Christopher Sjöwall, et al.
Published: (2024-03-01)